jumbo phages have expanded genomes conferring them unique
biological properties, of high
potential to develop novel
Therapeutics targeting diseases mediated by bacteria
News & PRess
> nov '23
Nova awards winner
Uruguayan Innovation Awards: Recognition in the Startup Category
Kinzbio won the NOVA Award in the StartUp category for its contributions to the field of antimicrobial research. Specifically recognized for their pioneering work in "Jumbo Phages for the Development of New Anti-bacterial Tools and Other Biomedical Applications."
The NOVA Awards by ANII aim to celebrate impactful initiatives, foster an innovative culture across diverse sectors, and highlight success stories that underscore Uruguay's capacity for innovation.
This acknowledgment serves as motivation, inspiring us to persist in our innovative pursuits for a better world.
unleashing the potential of
Kinzbio fosters collaborations and partnerships with pharma leaders, clinical organizations, academic labs and funding agencies to help the company to accelerate the development of its jumbo phage platform and pipeline.
Kinzbio has an open communication channel with and is always seeking to hear from industry partners and funding institutions interested in joining efforts to keep developing applications based on the biology of jumbo phages.
Please fill your contact details below:
Phage technologies for a